PMID- 35997119 OWN - NLM STAT- MEDLINE DCOM- 20220824 LR - 20220919 IS - 1045-4403 (Print) IS - 1045-4403 (Linking) VI - 32 IP - 6 DP - 2022 TI - LncRNA ZFPM2-AS1 Enhances Retinoblastoma Development by Targeting the miR-3612/NT5E Signaling Axis. PG - 69-82 LID - 10.1615/CritRevEukaryotGeneExpr.2022042697 [doi] AB - Background - Retinoblastoma (RB) is an intraocular malignancy usually observed in children. The zinc finger protein, FOG family member 2 (ZFPM2)-antisense RNA 1 (AS1), an anomalous long non-coding RNA, is detected in many cancers. This study aimed to evaluate the role and underlying mechanism of ZFPM2-AS1 in RB. Methods - ZFPM2-AS1, 5'-nucleotidase ecto (NT5E), and microRNA (miR)-3612 expression levels were determined in RB cells and tissues. Multiple experiments, including cell counting kit-8, 5'-bromo-2'-deoxyuridine, transwell, and enzyme-linked immunosorbent assays, were conducted to evaluate their effects on cell proliferation, migration, and apoptosis. Additionally, the ZFPM2-AS1/miR-3612/NT5E axis was validated using luciferase reporter, anti-AGO2 RNA immunoprecipitation, and RNA pull-down assays. Results - Overexpression of ZFPM2-AS1 and NT5E and downregulation of miR-3612 expression levels were observed in RB cells and tissues. Knockdown of ZFPM2-AS1 decreased the proliferation and migration of RB cells, while enhancing their apoptosis. The ZFPM2-AS1/miR-3612/NT5E axis was further supported by the negative correlation between miR-3612 expression levels and ZFPM2-AS1 or NT5E expression levels in RB tissues. Moreover, the miR-3612 inhibitor restored the inhibitory effect on the malignant behavior of RB cells by silencing ZFPM2-AS1. Furthermore, NT5E silencing phenocopied the effect of ZFPM2-AS1 silencing and abolished miR-3612 inhibitor-induced stimulation of the malignant behavior of RB cells. Conclusion - These results suggest that by targeting the miR-3612/NT5E axis, ZFPM2-AS1 stimulates the proliferation and migration of RB cells, while inhibiting their apoptosis. Therefore, ZFPM2-AS1 may be a promising therapeutic target associated with RB development. FAU - Ai, Kui AU - Ai K AD - Department of Pediatrics, Wuhan Third Hospital Guanggu district, Wuhan 430074, Hubei, China. FAU - Ni, Wenchang AU - Ni W AD - Department of Pediatrics, Wuhan Third Hospital Guanggu district, Wuhan 430074, Hubei, China. FAU - Li, Zhen AU - Li Z AD - Department of Pediatrics, Wuhan Third Hospital Guanggu district, Wuhan 430074, Hubei, China. LA - eng PT - Journal Article PL - United States TA - Crit Rev Eukaryot Gene Expr JT - Critical reviews in eukaryotic gene expression JID - 9007261 RN - 0 (DNA-Binding Proteins) RN - 0 (GPI-Linked Proteins) RN - 0 (MIRN3612 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (RNA, Antisense) RN - 0 (RNA, Long Noncoding) RN - 0 (Transcription Factors) RN - 0 (ZFPM2 protein, human) RN - EC 3.1.3.5 (5'-Nucleotidase) RN - EC 3.1.3.5 (NT5E protein, human) SB - IM MH - *5'-Nucleotidase/genetics MH - Cell Line, Tumor MH - Cell Movement/genetics MH - Cell Proliferation/genetics MH - Child MH - DNA-Binding Proteins/genetics MH - Family MH - *GPI-Linked Proteins/genetics MH - Gene Expression Regulation, Neoplastic MH - Humans MH - *MicroRNAs/genetics MH - RNA, Antisense/genetics MH - *RNA, Long Noncoding/genetics MH - *Retinoblastoma/genetics MH - Transcription Factors/genetics MH - Zinc Fingers EDAT- 2022/08/24 06:00 MHDA- 2022/08/25 06:00 CRDT- 2022/08/23 06:03 PHST- 2022/08/23 06:03 [entrez] PHST- 2022/08/24 06:00 [pubmed] PHST- 2022/08/25 06:00 [medline] AID - 40058b3a3fcd229f,2e5d55e5799acb4f [pii] AID - 10.1615/CritRevEukaryotGeneExpr.2022042697 [doi] PST - ppublish SO - Crit Rev Eukaryot Gene Expr. 2022;32(6):69-82. doi: 10.1615/CritRevEukaryotGeneExpr.2022042697.